InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Explore the full record of transactions filed by Bradsher Neal C, 董事. Insider active across 1 company, notably Lineage Cell Therapeutics, Inc.. In total, 1 reports have been logged. Activity tracked since 25 June 2021. The latest transaction was filed on 25 June 2021 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Bradsher Neal C
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报1 总计
24,720 股@ US$2.20100.0% 占其流量Common SharesSEC:0000919574-21-004286:0
1 条申报中的 1 条
About Bradsher Neal C
Neal C. Bradsher is a Board Member at Lineage Cell Therapeutics, Inc. He participates in overseeing the company's activities and strategic decision-making. His experience in the biopharmaceutical sector allows him to make significant contributions to the board.
